Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07090122 · ClinicalTrials.gov registry record · NA
Radiofrequency Ablation/Bone Augmentation + Radiotherapy vs Radiotherapy Alone
A NA study of Spine Metastases and Bone Pain, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT07090122 is a NA study of Spine Metastases and Bone Pain that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 36 participants, below the 488-participant average among 7 other Spine Metastases trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07090122, a NA study of Spine Metastases and Bone Pain, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-center, randomized controlled pilot study of radiofrequency ablation and bone augmentation (RFA/BA) plus radiotherapy (RT) vs. RT alone in patients with metastatic T5-L5 disease of the spine. Patients will be randomized 2:1 to receive either one treatment of RFA/BA plus RT or RT to evaluate the occurrence of skeletal-related events. Skeletal-related events (SREs) are defined as new clinical or radiologic evidence of pathologic fracture, spinal cord or nerve root compression, pain or instability, and/or necessity for additional local intervention (i.e. surgery, repeat RFA/BA or RT) due to persistent or progressive symptoms. Post-treatment follow-up for SREs are assessed at 1, 3, 6, 12, and 24 months.
Conditions Studied
Interventions
- PROCEDURE Radiofrequency ablation and bone augmentation with radiotherapy
- PROCEDURE Radiotherapy alone
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2028-06-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07090122
The ClinicalTrials.gov registry entry for NCT07090122 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 488-participant average among 7 other Spine Metastases trials with a reported enrollment target (93% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Spine Metastases appearing as the primary indexed condition, and to 2 interventions - of which Radiofrequency ablation and bone augmentation with radiotherapy is the first listed.
NCT07090122 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT07090122 about?
NCT07090122 is a clinical study titled "Radiofrequency Ablation/Bone Augmentation + Radiotherapy vs Radiotherapy Alone". This is a single-center, randomized controlled pilot study of radiofrequency ablation and bone augmentation (RFA/BA) plus radiotherapy (RT) vs. RT alone in patients with metastatic T5-L5 disease of the spine. Patients will be randomized 2:1 to receive either one treatment of RFA/BA plus RT or RT to ...
What is the current status of trial NCT07090122?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2025-12-01. Estimated completion is 2028-06-13.
What conditions does trial NCT07090122 study?
This clinical trial studies the following conditions: Spine Metastases, Bone Pain.
What interventions are being tested in trial NCT07090122?
The interventions under investigation include: Radiofrequency ablation and bone augmentation with radiotherapy (PROCEDURE), Radiotherapy alone (PROCEDURE).
Who is sponsoring clinical trial NCT07090122?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07090122 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spine Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases
RECRUITING · NA
-
Dose-Escalated Spine SbRT for Localized Metastasis to the Spinal Column
RECRUITING · NA
-
Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation
ACTIVE NOT RECRUITING · NA
-
Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease
RECRUITING · Phase 1
-
Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases
RECRUITING · Phase 2
-
Definitive Radiation for High-Risk Spine Metastases
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.